A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
Clinical trial NCT06470191 · RECRUITING
Trial details
- NCT number
- NCT06470191
- Sponsor
- Shanghai Jiaolian Drug Research and Development Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2026-12-31
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.